Tag: pharmaceutical patents

Federal Circuit Court: Authority on Pharmaceutical Patent Cases

Barbara Lalicki July 28, 2026 Medications 0 Comments

Explore the Federal Circuit's exclusive authority over pharmaceutical patent cases, covering key precedents like Mylan, Hatch-Waxman disputes, and the impact on generic drug timelines.

Evergreening: How Pharmaceutical Brands Stretch Patents to Block Generic Drugs

Barbara Lalicki December 28, 2025 Medications 16 Comments

Evergreening lets pharmaceutical companies extend patents on old drugs through minor tweaks, blocking generics and keeping prices high. Learn how it works, who does it, and why it hurts patients.